# EDGAR Filing Document

**Accession Number:** 0002084190
**File Stem:** 0001127602-25-021065
**Filing Date:** 2025-9
**Character Count:** 8897
**Document Hash:** 9c4c1fcb2dffbc94907794dc4148e79a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-25-021065.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001127602-25-021065

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250815

**FILED AS OF DATE**: 20250902

**DATE AS OF CHANGE**: 20250902

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Mowad-Nassar Nicole
- **CENTRAL INDEX KEY:** 0002084190

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15317
- **FILM NUMBER:** 251284964

**MAIL ADDRESS:**
- **STREET 1:** 809 W. EVERETT ROAD
- **CITY:** LAKE FOREST
- **STATE:** IL
- **ZIP:** 60045
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RESMED INC
- **CENTRAL INDEX KEY:** 0000943819
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 980152841
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**BUSINESS ADDRESS:**
- **STREET 1:** 9001 SPECTRUM CENTER BLVD.
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92123
- **BUSINESS PHONE:** 8587462400

**MAIL ADDRESS:**
- **STREET 1:** 9001 SPECTRUM CENTER BLVD.
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92123

## Ex-24

```

POWER OF ATTORNEY

The undersigned hereby makes, constitutes and appoints each of Lisa Beyer,
Julie Hutt, Joseph Yim, Michael Rider, Gladimera Gaditano
and Michelle Betancourt, or either of them acting singly,
and with full power of substitution, re-substitution and delegation,
the undersigned?s true and lawful attorney in fact
(each of such persons and their substitutes and delegees being referred to
herein as the ?Attorney-in-Fact?), with full power to act for the undersigned
and in the undersigned?s name, place and stead, in the undersigned?s capacity
as an officer, director or stockholder of ResMed Inc. (the ?Company?), to:

       1. Prepare and execute any and all forms, schedules and other documents
          (including any amendments thereto) the undersigned is required to
          file with the U.S. Securities and Exchange Commission (?SEC?), or
          which the Attorney-in-Fact  considers it advisable for the
          undersigned to file with the SEC, under Section 13  or Section 16 of
          the Securities Exchange Act of 1934 or any rule or regulation
           thereunder, or under Rule 144 under the Securities Act of 1933
           (?Rule 144?), including Forms 3, 4 and 5, Schedules 13D and 13G, and
           Forms 144 (all such forms, schedules and other documents being
           referred to  herein as ?SEC Filings?);

       2. Submit and file SEC Filings with the SEC utilizing the SEC?s
           Electronic Data Gathering and Retrieval (?EDGAR?) system
           or cause them to be submitted and filed;

       3. File, submit or otherwise deliver SEC Filings to
           any securities exchange on which the Company?s securities may be
           listed or traded; and

       4. Obtain, as the undersigned?s representative and
          on the undersigned?s behalf, information regarding
          transactions in the Company?s equity securities from any third
          party, including the Company and any brokers, dealers, employee
          benefit plan administrators and trustees, and the
          undersigned hereby authorizes any such third party to
          release any such information to the Attorney-in-Fact.

The undersigned acknowledges that:

          a. This Power of Attorney authorizes, but does not require,
           the Attorney-in-Fact to act in his or her discretion on information
           provided to such Attorney-in-Fact without independent verification of
           such information;

          b. Any documents prepared or executed by the Attorney-in-Fact
           on behalf of the undersigned pursuant to this Power of Attorney
           will be in such form and will contain such information as the
           Attorney-in-Fact, in his or her discretion, deems necessary
           or desirable;

          c. Neither the Company nor the Attorney-in-Fact assumes
           any liability for the undersigned?s responsibility to comply with
           the requirements of Section 13 or Section 16 of the Exchange Act
           or Rule 144, any liability of the undersigned for any failure to
           comply with such requirements, or any liability
           of the undersigned for disgorgement of profits under
           Section 16(b) of the Exchange Act; and

          d. This Power of Attorney does not relieve the undersigned
           from responsibility for compliance with the undersigned?s
           obligations under Section 13 or Section 16 of the Exchange Act,
           including, without limitation, the reporting requirements
           under Section 13 or Section 16 of the Exchange Act.

The undersigned hereby grants to the Attorney-in-Fact full
power and authority to do and perform each and every act and thing requisite,
necessary or advisable to be done in connection with the foregoing,
as fully, to all intents and purposes, as the undersigned might or could do
in person, hereby ratifying and confirming all that the Attorney-in-Fact,
or his or her substitute or substitutes, shall lawfully do or cause
to be done by authority of this Power of Attorney.

This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 4 or 5
or Schedules 13D or 13G or Forms 144 with respect to the undersigned?s
holdings of and transactions in securities of the Company, unless earlier
revoked by the undersigned in a signed writing delivered to the
Attorney-in-Fact. This Power of Attorney revokes all previous powers of
attorney with respect to the subject matter of this Power of Attorney.

[Signature Page to Follow]

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney
as of August 18, 2025.

/s/ Nicole Mowad-Nassar
Signature

Nicole Mowad-Nassar
Print Name

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Mowad-Nassar Nicole<br><sub>(Last) (First) (Middle)</sub><br>9001 SPECTRUM CENTER BLVD<br><sub>(Street)</sub><br>SAN DIEGO, CA 92123<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>RESMED INC [ RMD ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-08-15 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

**Signature:** /s/ Michael Rider, attorney-in-fact for Ms. Mowad-Nassar  
**Date:** 2025-09-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**